HF
LFCR icon

HRT Financial’s Lifecore Biomedical LFCR Stock Holding History

HRT Financial’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,038
Closed -$213K – 3634
2025
Q3 		$213K Buy
+29,038
New +$220K ﹤0.01% 2376
2025
Q2 		– Sell
-13,029
Closed -$91K – 3159
2025
Q1 		$91K Buy
+13,029
New +$81K ﹤0.01% 2163
2024
Q1 		– Sell
-19,353
Closed -$119K – 2736
2023
Q4 		$119K Buy
+19,353
New +$134K ﹤0.01% 1873
2023
Q3 		– Sell
-28,459
Closed -$275K – 2790
2023
Q2 		$275K Buy
+28,459
New +$174K ﹤0.01% 1678
2022
Q1 		– Sell
-30,997
Closed -$344K – 3500
2021
Q4 		$344K Buy
30,997
+9,171
+42% +$89K ﹤0.01% 2170
2021
Q3 		$201K Buy
21,826
+6,627
+44% +$72.1K ﹤0.01% 2689
2021
Q2 		$170K Buy
+15,199
New +$175K ﹤0.01% 2450

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return

HRT Financial's LFCR Position: Q4 2025 in Review

HRT Financial sold out of Lifecore Biomedical (LFCR) in Q4 2025, closing a stake of 29,038 shares — an estimated $213K sold.

HRT Financial first reported a position in LFCR in Q2 2021 and held it in 7 quarters. The position peaked at $344K in Q4 2021. 103 funds tracked by Wall St. Rank hold LFCR as of Q4 2025.

  • HRT Financial reported no remaining Lifecore Biomedical position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 29,038 Lifecore Biomedical shares in Q4 2025, an estimated $213K.
  • HRT Financial first reported a position in Lifecore Biomedical in Q2 2021 and held it in 7 quarters.
  • HRT Financial's Lifecore Biomedical position peaked at $344K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.